Leading small business
innovation and commercialization
in the fight against cancer
The SBIR & STTR Programs are one of the largest sources of early stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities.
Learn how NCI SBIR & STTR Programs have helped small businesses with funding awards that help advance cancer research.
Their MxStructure™ software uses auto-segmentation to better focus radiation treatment and minimize exposure to surrounding healthy tissue. They were acquired by Accuray in 2012.
AntiCancer, the San Diego-based biotechnology company, was awarded Phase I and II SBIR grants and contracts that have led to the commercialization of three cancer research tools: MetaMouse®, AngioMouse®, and OncoBrite®.
Awarded more than $4 million to develop a technology platform of safe and effective carriers for therapeutic vaccines based on hemocyanin from the keyhole limpet (KLH) protein.
Have you ever wanted a system that checks your grant application for errors BEFORE you submit it? Small businesses may now use ASSIST to submit SBIR and STTR grant applications.
Through this FOA, eligible small businesses may partner with NIH intramural labs to bring technologies to market.
Join NCI SBIR Program staff for a webinar that will cover the SBIR and STTR Programs, which fund and support small biomedical technology companies, as well as funding opportunities, and Tips on Applying.
The NCI SBIR Program released 14 new opportunities and has a new electronic submissions process. The deadline to apply for FY2016 contract topics is October 16, 2015 by 5:00 PM EDT
Applying to the FY2016 Contract Solicitation? Check out these webinar materials for helpful information and tips.
This site is undergoing remediation for compliance with Section 508. The remediation will be complete by September 30, 2015.
In the interim, should you require any accessibility assistance with any content, please contact NCI SBIR & STTR